Bliss GVS Pharma
BLISSGVS · Pharma > Pharmaceuticals & Drugs · Chairman: S R Vaidya · MD: Gagan Harsh Sharma · Listing date: July 26, 2010 · Employees: 683 · Mumbai · http://www.blissgvs.com

Stock Price vs Company Growth
1d
4.2%
1w
15.3%
1m
52.1%
3m
71.7%
6m
226.5%
1y
372.8%
5y
46.5%
10y
17.7%
all
20.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 726 4.2%
424
726
Company Overview

Sales
1,005 Cr
Growth: 13.6%
Profit after Tax
136 Cr
Growth: 5.5%
Mid Cap
7,719 Cr
P/E: 57.5x
Industry P/E: 34.2x
Fundamentals

Sales (Cr) ₹ 1,005
Growth 13.6%
EBITDA 18.6%
P/S 7.7x
Dividend 0.5%
P/E 57.5x
Book Value ₹ 117
PEG Ratio 3.9x
ROE 11.6%
P/B 5.7x
Shareholding Pattern

Institutions
Arian Investment Ltd
9.7 %
Life Insurance Corporation Of India
6.68 %
Polus Global Fund
4.62 %
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund
2.9 %
Aspire Emerging Fund
2.46 %
Promoters
Narsimha Shibroor Kamath
33.24 %
Others
Gulbarga Trading And Investment Pvt. Ltd.
5.67 %
Arjun Gautam Ashra
4.89 %
Gautam Rasiklal Ashra
2.82 %
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs
2.2 %
Llp
0.05 %
Increase    Decrease    No change
Company Profile Detailed

It is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. The company’s most unique product is ‘Today Vaginal Contraceptive’, a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception.
Investors (65)
Followers (10)